Temple Health pilots AI glucose tool

Temple Health is using an artificial intelligence-guided insulin dosing system to reduce dangerous blood-sugar swings in hospitalized patients with diabetes, according to Temple Health and recent local media reports. The Philadelphia health system says the software, EndoTool Sub-Q, predicts glucose trends and recommends subcutaneous insulin doses for individual inpatients. Temple Health said the system has already reduced hypoglycemia rates by two- to threefold across the health system. The rollout puts a concrete number on a common hospital problem: keeping patients in a safe glucose range while avoiding insulin-driven lows. ### What exactly is Temple Health piloting? Temple Health identified the tool as EndoTool Sub-Q, a predictive software system used for inpatient diabetes management. In an August 15, 2025 Temple Health newsroom post, Benjamin Slovis, chief medical information officer at Temple University Hospital, said the software “uses algorithms to model, predict, and adapt subcutaneous insulin dosing recommendations for each patient.” Temple Health’s May 22, 2026 media summary said The Philadelphia Inquirer reported on the same implementation and described it as an AI-powered insulin dosing system. (templehealth.org) The system is aimed at hospitalized patients rather than outpatients using home diabetes devices. Temple Health’s materials describe it as a bedside clinical decision-support tool that helps care teams manage insulin dosing in real time during inpatient stays. ### How does the software change care on the hospital floor? Temple Health said the software tracks patient-specific glucose patterns and generates dosing guidance intended to keep patients within target range. (templehealth.org) The health system said the program supports subcutaneous insulin protocols and helps clinicians move away from less individualized approaches. A case study posted by Monarch Medical Technologies, the company behind EndoTool, said Temple adopted the system to improve glycemic control and reduce hypoglycemia linked to reliance on sliding-scale insulin. Samantha Messick, a neuroscience intensive care unit nurse interviewed in Temple Health’s May 22, 2026 media summary, was cited as part of the team using the system in practice. Temple Health said the software has also improved clinicians’ ability to keep patients within target glucose ranges. ### What results has Temple Health reported so far? Temple Health said the most visible result has been a two- to threefold reduction in hypoglycemia across the health system. (templehealth.org) The same August 2025 Temple Health report described the software as a systemwide implementation and tied the improvement to inpatient glycemic safety efforts. NBC10 and The Philadelphia Inquirer were later cited by Temple Health in 2026 summaries describing the tool as a “game changer” and reporting the same reduction range. (templehealth.org) Monarch Medical Technologies said Temple Health reduced hypoglycemia by more than 70%, though that figure appears in vendor materials rather than Temple’s own newsroom summary. Temple’s published language has been more conservative, repeatedly describing the improvement as a two- to threefold reduction. ### Why are glucose swings in the hospital such a focus? Hypoglycemia is a patient-safety issue in hospitals because insulin treatment can push blood sugar too low while illness, surgery, steroids and changing nutrition can also drive rapid swings. (templehealth.org) Temple Health said the software was designed to anticipate those shifts and help clinicians adjust sooner. Slovis said in Temple’s 2025 report that the goal was to improve glycemic control while reducing severe lows. (monarchmedtech.com) Temple’s public materials frame the project as operational as well as clinical. The health system said individualized dosing recommendations can help standardize inpatient diabetes management across campuses and units. ### What comes next in this rollout? Temple Health said in 2025 and 2026 updates that the EndoTool Sub-Q rollout had expanded across the health system and that staff training was part of the implementation. (templehealth.org) Becker’s Hospital Review reported in September 2025 that Temple had launched the software through a phased, multi-campus rollout, and Temple’s May 22, 2026 update said local media were still tracking the program’s results. The next public datapoints are likely to come through additional Temple Health updates, hospital case studies or conference presentations from named leaders including Slovis and Temple nursing and clinical operations executives. (beckershospitalreview.com)